TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Cryogenetics AS
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
27,109
|
22,025
|
21,233 |
| Financial expenses |
712
|
664
|
560 |
| Earnings before taxes |
5,689
|
2,591
|
2,750 |
| Total assets |
34,605
|
31,172
|
27,375 |
| Current assets |
17,417
|
16,523
|
15,849 |
| Current liabilities |
5,801
|
6,807
|
5,435 |
| Equity capital |
21,210
|
16,979
|
14,753 |
| - share capital |
2,936
|
3,128
|
3,302 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
61.3%
|
54.5%
|
53.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
21.0%
|
11.8%
|
13.0% |
| Return on assets (ROA) |
18.5%
|
10.4%
|
12.1% |
| Current ratio |
300.2%
|
242.7%
|
291.6% |
| Return on equity (ROE) |
26.8%
|
15.3%
|
18.6% |
| Change turnover |
6,437
|
1,907
|
3,750 |
| Change turnover % |
31%
|
9%
|
21% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.